ENTRY       D12151                      Drug
NAME        Ianalumab (USAN/INN)
FORMULA     C6606H10224N1740O2098S40
EXACT_MASS  148777.5656
MOL_WEIGHT  148868.862
SEQUENCE    (Heavy chain)
            XVQLQQSGPG LVKPSQTLSL TCAISGDSVS SNSAAWGWIR QSPGRGLEWL GRIYYRSKWY
            NSYAVSVKSR ITINPDTSKN QFSLQLNSVT PEDTAVYYCA RYDWVPKIGV FDSWGQGTLV
            TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
            LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE
            LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
            EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP
            SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
            KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPG
            (Light chain)
            DIVLTQSPAT LSLSPGERAT LSCRASQFIS SSYLSWYQQK PGQAPRLLIY GSSSRATGVP
            ARFSGSGSGT DFTLTISSLE PEDFAVYYCQ QLYSSPMTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H99, H227-L215, H151-H207, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'99, H'227-L'215, H'151-H'207, H'268-H'328, H'374-H'432, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Immunomodulator
  TYPE      Monoclonal antibody
COMMENT     Treatment of autoimmune diseases and cancer immunotherapy
TARGET      TNFRSF13C (BAFF-R, CD268) [HSA:115650] [KO:K05151]
  PATHWAY   hsa04060(115650)  Cytokine-cytokine receptor interaction
            hsa04064(115650)  NF-kappa B signaling pathway
            hsa04672(115650)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF13C (BAFF-R, CD268)
                 D12151  Ianalumab (USAN/INN)
DBLINKS     CAS: 1929549-92-7
///
